Jump to section
To ensure patients are receiving the right treatment at the right time.
12% employee growth in 12 months
Pharma companies have traditionally lagged other industries when it comes to programmatic advertising use. That has much to do with the unique targeting and regulatory requirements of these companies.
In many ways, it's a situation which means that pharma companies are relatively poor at a central plank of their wellness service - communication. It's from this angle that DeepIntent was created to solve this issue.
The startup is building a marketplace that combines offline health data with online identity, allowing media buyers and sellers to transact within a single privacy-safe, data-rich environment.
DeepIntent’s strategies for growth revolve around expanding this marketplace. That means onboarding more suppliers of both types of datasets, arranging new transaction channels, and winning more healthcare buyers. In 2023, it launched the DeepIntent Operating System, which will help Connected TV platforms analyse audience measurements and optimise pharmaceutical advertising performance.
Steph
Company Specialist at Welcome to the Jungle
Chris Paquette
(CEO)Previously worked as a Memorial Sloan Kettering data scientist.